As soon as you have applied or filed for protection, you can sell, license (i.e., 'lease’), or pledge your rights.
When you sell your rights, you transfer them to someone else. You can sell a protective right from the start, for instance, when you don’t want to market it yourself. This way you immediately receive the agreed upon sum, independently of the future value of the title. Or you can wait and transfer the protective right after the resulting product has been successfully marketed. Under licensing, the title owner (licensor) retains his rights. But he makes an agreement with the licensee on the manner and time period for which the protective right may be used and how the benefits will be managed.
We recommend retaining a specialized attorney for negotiating and writing sale and licensing contracts.
If you own the rights it might be easier to find investors. A protective title can also be used as a collateral for investors under certain conditions.
Good to know
- Who owns the rights to an invention or design created as part of an employment relationship?
First, check if the employment contract deals with this issue. If it doesn’t, then article 332 of the Swiss Obligation Code is applicable. According to this law, inventions and designs belong to the employer if they are made in fulfillment of contractual obligations. Inventions and designs created during regular work time but not under the contractual obligations must be offered to the employer. Then the employer can decide whether he wants to obtain the invention or design in question.
- Including intellectual property in the bookkeeping is an important and complex subject. Consult a financial expert or auditing office.
Study shows that points of contact for Swiss inventors and creatives score highly
01.01.2021 | Law and policy
The sic! journal in partnership with the Helbing Lichtenhahn Verlag from 2021
The ‘Swiss’ brand is adequately protected
Swiss Innovation Forum 2020 to be held as an online festival
08.11.2019 | Event
Symposium on Creative Approaches to Improving Access to Medicines Globally